ID: ALA232065

Max Phase: Preclinical

Molecular Formula: C11H13BrN2

Molecular Weight: 173.24

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  Cn1cc[n+](Cc2ccccc2)c1.[Br-]

Standard InChI:  InChI=1S/C11H13N2.BrH/c1-12-7-8-13(10-12)9-11-5-3-2-4-6-11;/h2-8,10H,9H2,1H3;1H/q+1;/p-1

Standard InChI Key:  VBLZTUCAWYJIMG-UHFFFAOYSA-M

Associated Targets(Human)

U-937/GTB 73 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

ACHN 49357 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Mycobacterium tuberculosis 203094 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Staphylococcus aureus 210822 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Escherichia coli 133304 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 173.24Molecular Weight (Monoisotopic): 173.1073AlogP: 1.36#Rotatable Bonds: 2
Polar Surface Area: 8.81Molecular Species: NEUTRALHBA: 1HBD: 0
#RO5 Violations: 0HBA (Lipinski): 2HBD (Lipinski): 0#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: CX LogP: -1.75CX LogD: -1.75
Aromatic Rings: 2Heavy Atoms: 13QED Weighted: 0.61Np Likeness Score: -0.54

References

1. Vik A, Hedner E, Charnock C, Tangen LW, Samuelsen Ø, Larsson R, Bohlin L, Gundersen LL..  (2007)  Antimicrobial and cytotoxic activity of agelasine and agelasimine analogs.,  15  (12): [PMID:17442577] [10.1016/j.bmc.2007.03.086]

Source